This update contains important information for community pharmacy teams.

CPNI ALERTS

DOH(NI) ALERTS

BSO ALERTS

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.

Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Pricing/Supply Reporter and Situation Reporter.

Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive
Dear Colleague

I have been asked by Heather Moorehead, Director of the Northern Ireland Confederation for Health and Social Care (NICON) to circulate information associated with a process that NICON is taking forward to appoint a Primary Care Network Lead to help establish and lead a new Primary Care Network in Northern Ireland and, to encourage applications from the community pharmacy sector.

In December 2024, Minister of Health Mike Nesbitt published his Three Year Plan for Health and Social Care Northern Ireland (HSCNI). This was updated by a Reset Plan this week on 9th July 2025 with the plans setting out a clear aspiration to support moving care closer to home, using technology and investing in a much greater preventative approach. In this context there are significant opportunities for primary care stakeholders to play a key role in the delivery of these key strategic shifts.

Working closely with SPPG and local primary care stakeholders (including CPNI) and with the support of the NHS Confederation’s Primary Care Network, NICON has agreed that there is an opportunity to create a new Northern Ireland Primary Care Network.

NICON, on behalf of HSCNI, is now seeking to recruit a healthcare practitioner to establish and lead this new network. The Primary Care Network Lead will be a primary care clinician who will play a critical role in supporting the establishment and development of a thriving primary care network offering, which provides leadership and develops influential perspectives on behalf of primary care.

There is therefore a unique opportunity for a community pharmacist, who meets the role specification, to lead and play a formative role in both this new Primary Care Network and in the implementation of the Health Minister’s plans to modernise and reset the healthcare model in Northern Ireland as envisaged within the 3-Year HSCNI Plan and the Reset Plan.

Further information on this role is available here.

Please note the closing date for the Expression of Interest is Thursday 14 August 2025.

Please do not hesitate to contact CPNI offices ☎️(028) 9069-0444 should you require any additional information or if you wish to speak further about this unique opportunity.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor
The Department of Health NI has issued correspondence dated 10 July 2025 regarding the Seasonal Influenza Vaccination Programme 2025/26.

SUMMARY

The correspondence includes the following key points:

  • The Seasonal Influenza Vaccination programme is expected to commence in NI in early October 2025  (exact dates to be confirmed in due course).
  • It is expected that most vaccinations will be administered by early December 2025 to ensure those considered most at risk are protected.
  • There will be some patient cohorts who can be vaccinated in September e.g. pregnant women.
  • Where possible, this year’s influenza programme should be delivered in conjunction with this autumn’s COVID-19 programme, in order to optimise vaccine uptake and to ensure resources are deployed effectively and efficiently for both programmes. Please note, unlike in previous campaigns, eligibility for the COVID-19 2025/26 programme will not align with eligibility for the influenza programme.
  • A small pool of Sessional Vaccinators, employed by the Public Health Agency, are available to support GPs and Community Pharmacy with co-administration of the COVID-19 and influenza programmes throughout the Autumn campaign. Further information on this workforce and requests for support can be raised by contacting the PHA at: PHAVaccinesitrep@hscni.net
  • A separate HSS letter on the COVID-19 2025/2026 programme issued on 26 June 2025 and can be found here: HSS (MD) 23/2025 Autumn 2025 COVID 19 Vaccination Campaign

Vaccine Eligibility:

Those eligible for influenza vaccine in 2025/2026 are:

  • all those aged 65 years and over on 31 March 2026
  • all those aged 18 years to under 65 years in clinical risk groups (as defined by the influenza chapter in ‘Immunisation against infectious disease’ (the ‘Green Book’)
  • those in long-stay residential care homes
  • pregnant women
  • all preschool children aged two to four years on 1 September 2025
  • all school-aged children (up to and including year 12)
  • all children in clinical risk groups aged from 6 months to less than 18 years
  • carers
  • close contacts of immunocompromised individuals
  • high risk poultry and avian animal health workers
  • all health and social care workers

The Community Pharmacy Cohorts:

Community Pharmacies can vaccinate anyone from the following cohorts:

  • Health and Social Care workers
  • those aged 65 and over
  • for carers
  • for those aware of their ‘at risk’ status
  • those who are pregnant
  • All RQIA registered care home residents and staff

ACTION

  • Contractors providing vaccination services should review and note the DoH correspondence and share with relevant members of the pharmacy team.
  • Further operational information will be issued in due course.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
This update contains important information for community pharmacy teams.

CPNI ALERTS

DOH(NI) ALERTS

BSO ALERTS

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.

Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Pricing/Supply Reporter and Situation Reporter.

Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive
Dear Contractor
The July 2025 edition of the Pharmacy Technician Regulation Project Newsletter has been published on the Department of Health’s website.

SUMMARY

The latest edition of the Pharmacy Technician Regulation Project Newsletter  includes:

  • An update on the project work, including the revised timeline for completion by the end of 2027.
  • A survey to gather further information from student technicians who are currently undertaking the Level 3 Diploma.
  • A staff information poster inviting technicians, student technicians and pharmacy support staff to engage with the Technician Workforce Subgroup and provide more information on their role profiles and career pathways.

ACTION

Contractors should:

  • Note the contents of the Pharmacy Technician Newsletter and bring to the attention of relevant members of the pharmacy team.
  • Advise technician and support staff to join the Technician Regulation Project mailing list to receive all relevant updates.

Contractors can contact a member of the CPNI team should they have any queries on the Pharmacy Technician Regulation Project.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Colleague
The following concessionary prices granted in June 2025 have rolled over to July 2025:
DrugPack SizeConcessionary Price
Co-amoxiclav 250mg/62mg/5ml oral suspension100£5.06
Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free100£4.79
Fenofibrate micronised 160mg tablets28£3.60
Nizatidine 150mg capsules30£21.69
Sulfasalazine 500mg tablets112£6.61

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive